There’s room on the market for new TAVI valves as long as they can compete with the best in practice, a researcher says.

Truist lowered the firm’s price target on Medtronic (MDT) to $90 from $93 and keeps a Hold rating on the shares as part of a broad research ...

Edwards Lifesciences (NYSE:EW) recently announced significant findings at the ACC Annual Scientific Session, showcasing crucial research in the treatment of structural heart disease. This ...

As of 2:37:15 pm GMT-4. Market open.

At close: April 8 at 4:00:02 PM EDT ...

HighLife announced that it received FDA breakthrough device designation for its trans-septal mitral valve replacement (TMVR) solution. Paris-based HighLife — which has facilities in Irvine ...